Clinical trial
CellCept in p-ANCA Vasculitis
NCT00405860 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00405860 |
|---|---|
| Title | CellCept in p-ANCA Vasculitis |
| Official title | A Pilot Study of Mycophenolate Mofetil (MMF) in Patients With p-ANCA Microscopic Polyangiitis and Mild to Moderate Renal Dysfunction. |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | Roche Pharma AG Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | MPO-ANCA Vasculitis, Microscopic Polyangiitis |
| Intervention type | Drug |
| Interventions | CellCept (mycophenolate mofetil) |
| Enrollment | 18 |
| Start date | Dec 1, 2002 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Nov 30, 2006 |
| Last update posted | Mar 23, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: